共 50 条
- [42] Improved Late Clinical Safety With Zotarolimus-Eluting Stents Compared With Paclitaxel-Eluting Stents in Patients With De Novo Coronary Lesions 3-Year Follow-Up From the ENDEAVOR IV (Randomized Comparison of Zotarolimus- and Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease) Trial JACC-CARDIOVASCULAR INTERVENTIONS, 2010, 3 (10) : 1043 - 1050
- [44] Long-term safety of drospirenone-estradiol for hormone therapy: a randomized, double-blind, multicenter trial MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2005, 12 (06): : 716 - 727
- [45] A randomized, double-blind, placebo-controlled trial to evaluate the efficacy, safety, and tolerability of long-term treatment with prucalopride NEUROGASTROENTEROLOGY AND MOTILITY, 2015, 27 (06): : 805 - 815
- [50] A prospective multicenter parallel-controlled trial of TIVOLI biodegradable-polymer-based sirolimus-eluting stent compared to ENDEAVOR zotarolimus-eluting stent for the treatment of coronary artery disease: 8-month angiographic and 2-year clinical follow-up results CHINESE MEDICAL JOURNAL, 2011, 124 (06) : 811 - 816